The company's ISO certifications, including ISO 9001:2015 for the Development and Production of Dermatological Products and ISO 22716:2008 (ISO 22716:2007) for the Manufacture of Dermatological Products, speak to their commitment to quality and best practices in production.
UniPharma, S.A. has embarked on a growth trajectory with its strong distribution network currently spanning Albania, Bolivia, Costa Rica, Dominican Republic, Kuwait, Nicaragua, South Korea, and Uruguay. As they aim for global coverage, the company is actively exploring new markets and opportunities in all 5 continents, demonstrating a clear strategic vision for expansion.
The focus on Dermatological Solutions and the company's established presence in both the manufacturing and pharmaceutical industries position UniPharma, S.A. as an appealing investment opportunity for Venture Capitalists looking to support a company with a strong track record and a clear growth strategy.